High Cholesterol

The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study in the April 2 issue of JAMA.

Insulin resistance in brain cells can affect how they function, causing some of the biochemical changes typically seen in Alzheimer's disease.

Kidney dialysis patients with higher cholesterol levels die at a lower rate than those with lower cholesterol levels.

For the first time, Duke University Medical Center researchers have demonstrated that exercise -- without accompanying weight loss -- has a positive impact on improving cholesterol levels.

Researchers have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that could lead to new drugs to treat and reverse the effects of Type 2 diabetes and heart disease related to obesity.

Farm-raised tilapia has very low levels of beneficial omega-3 fatty acids and very high levels of omega-6 fatty acids. The combination could be potentially dangerous for some patients with heart disease, arthritis, asthma and other allergic and auto-immune diseases.

Scientists in Japan have shown that this waste product of rice processing, called rice bran, significantly lowers blood pressure in rats whose hypertension resembles that of humans.

Nutrition researchers at Kansas State University have published the first evidence that the absorption of cholesterol is reduced by another compound in the egg, a lecithin.

An estimated 63 million adults have low-density lipoprotein cholesterol (LDL-C) levels higher than what would be ideal as recommended.

Colesevelam hydrochloride appears to be an effective lipid-lowering agent that significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to a study published in the October issue of Mayo Clinic Proceedings.

The portfolio diet lowers cholesterol levels, reduces other risk factors for cardiovascular disease including blood pressure, triglycerides, inflammation, angina and more.

Researchers have identified a potential target for the development of new therapies to treat hypertriglyceridemia, a lipid disorder commonly seen in people who are obese and diabetic.

Niacin, a medication once discouraged for the treatment of lipid abnormalities in patients with diabetes, has the potential ability, when given in low doses, to be well-tolerated and effective.

Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus.

Individuals in a prediabetic state who were treated with the oral medication pioglitazone were 81 percent less likely to convert to diabetes than those who received a placebo.

Metabolic Syndrome X is the term used to describe a group of heart disease risk factors.